A joint initiative to understand blood generation in health and disease
- Hemato-Linné is an excellence research environment in hematopoiesis at Lund University.
- Financed by the Swedish Research Council through a 10-year Linnaeus grant, Hemato-Linné was established in 2006 as a world-leading research environment to study the regulation of normal and leukemic hematopoietic stem cells and blood lineage development. Read more about Hemato-Linné at the Swedish Research Council
- Hemato-Linné consists of 15 collaborating research groups with complementary competences and a track record of successful collaborative projects.
- Hemato-Linné also focuses on excellence in research training and career development of young scientists.
- To understand the cellular and molecular regulation of hematopoietic stem cell self renewal and lineage commitment.
- To understand how these processes are perturbed in hematological disorders.
Professor Eva Hellström Lindberg from the Department of Medicine, Huddinge, Karolinska Insitutet, Stockholm, Sweden will be visiting Lund on October 22 - 23, 2015 in connection with Maria Dahl's thesis defense.
She will give a lecture entitled "Unravelling the genotype-phenotype relation in splice-factor SF3B1 mutated sideroblastic anemia" on Friday October 23 at 10:00 in the seminar room I1345.
Professor Juan Bueren from the Division of Hematopoietic Innovative Therapies, CIEMAT/ CIBERER, Madrid, Spain will be visiting Lund on October 22 - 23, 2015 in connection with Maria Dahl's thesis defense.
He will give a lecture entitled "Lentiviral-mediated gene therapy and gene editing in Fanconi anemia" on Thursday October 22 at 16:00 in the seminar room I1345.
The immune system recognizes and protects our body against different types of pathogens and is divided into the innate and adaptive immunity. While the adaptive T and B lymphocytes provide long-lasting specific protection, the innate immune system represents the fast first line of the defense. Natural killer (NK) cells are lymphocytes that belong to the innate immune system, where they play a central role in rapidly eliminating virus-infected and transformed cancer cells. NK-cells are not only specialized in killing these target cells, but they also produce regulatory cytokines that increase the response of the adaptive immune system.
Professor Timothy M Cox from the Department of Medicine, University of Cambridge, United Kingdom will be visiting Lund on September 9 - 12, 2015.
He will give a lecture entitled "Innovative therapies for Gaucher disease" on Thursday September 10 at 16:00 in Segerfalk lecture hall, BMC A10.
Congratulations to Stefan Scheding, who was recently awarded 2 million SEK funding from The Swedish Childhood Cancer Foundation to develop a method that enables the removal of tumor cells from stem cell transplants. This year, six out of ten proposals within the call for research and development projects in medical engineering received funding.